Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C420084 |
1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester |
1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16818512
|
C074153 |
1,4-phenylenebis(methylene)selenocyanate |
1,4-phenylenebis(methylene)selenocyanate results in decreased expression of CTNNB1 protein | decreases expression | 10753194
|
C103958 |
1-hydroxyvitamin D5 |
1-hydroxyvitamin D5 results in decreased expression of CTNNB1 protein | decreases expression | 16051482
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [DEFA2 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of CTNNB1 mRNA | increases expression | 20406850
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CTNNB1 mRNA | affects expression | 21346803
|
C487689 |
(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in decreased expression of CTNNB1 mRNA | decreases expression | 17261273
|
C022830 |
2-methoxyestradiol |
2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | decreases reaction|decreases response to substance | 18485479
|
C022830 |
2-methoxyestradiol |
2-methoxyestradiol results in decreased expression of CTNNB1 mRNA | decreases expression | 18485479
|
C022830 |
2-methoxyestradiol |
2-methoxyestradiol results in decreased expression of CTNNB1 protein | decreases expression | 18485479
|
C417520 |
3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione |
[3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein | decreases activity|increases expression | 19159680
|
C025160 |
3-aminobenzamide |
3-aminobenzamide results in decreased expression of CTNNB1 mRNA | decreases expression | 15670817
|
C048460 |
3-deazaneplanocin |
[3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein | affects cotreatment|affects expression | 18538736
|
C002010 |
4-(2-aminoethyl)benzenesulfonylfluoride |
4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] | decreases localization|decreases reaction | 17030184
|
C002010 |
4-(2-aminoethyl)benzenesulfonylfluoride |
4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in increased degradation of and results in decreased activity of CTNNB1 protein] | decreases activity|decreases reaction|increases degradation | 17030184
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of CTNNB1 mRNA | increases expression | 18648102
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of CTNNB1 mRNA | decreases expression | 12419474
|
C439285 |
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride |
(5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in decreased expression of CTNNB1 protein | decreases expression | 12392815
|
C483321 |
6-bromoindirubin-3'-oxime |
6-bromoindirubin-3'-oxime results in increased expression of CTNNB1 protein | increases expression | 18624906
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CTNNB1 mRNA | affects expression | 17562736
|
D000171 |
Acrolein |
Acrolein results in increased expression of CTNNB1 protein | increases expression | 20525806
|
D000641 |
Ammonia |
CTNNB1 protein affects the metabolism of Ammonia | affects metabolic processing | 16557553
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CTNNB1 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in increased expression of CTNNB1 protein | increases expression | 16483693
|
D000661 |
Amphetamine |
Amphetamine results in decreased expression of CTNNB1 protein | decreases expression | 16144542
|
C526219 |
apple polyphenol extract |
apple polyphenol extract results in decreased expression of CTNNB1 protein | decreases expression | 16968061
|
C526219 |
apple polyphenol extract |
apple polyphenol extract results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 16968061
|
C006632 |
arsenic trioxide |
arsenic trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | decreases reaction|decreases response to substance | 18485479
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CTNNB1 mRNA | decreases expression | 18485479
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of CTNNB1 protein | decreases expression | 18485479 17512576
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of CTNNB1 mRNA | increases expression | 20458559
|
C015001 |
arsenite |
arsenite affects the localization of CTNNB1 protein | affects localization | 17400267
|
C015001 |
arsenite |
arsenite results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 17400267
|
C015001 |
arsenite |
tyrphostin AG 1478 inhibits the reaction [arsenite affects the localization of CTNNB1 protein] | affects localization|decreases reaction | 17400267
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of CTNNB1 mRNA | affects expression | 17331233
|
D001241 |
Aspirin |
Aspirin results in increased phosphorylation of CTNNB1 protein | increases phosphorylation | 12813129
|
D001241 |
Aspirin |
Lithium Chloride inhibits the reaction [Aspirin results in increased phosphorylation of CTNNB1 protein] | decreases reaction|increases phosphorylation | 12813129
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 14555707
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 14555707
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17219422
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Nitroglycerin results in increased degradation of CTNNB1 protein] | increases degradation|increases reaction | 17030184
|
C400082 |
bortezomib |
2-methoxyestradiol inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | decreases reaction|decreases response to substance | 18485479
|
C400082 |
bortezomib |
arsenic trioxide inhibits the reaction [CTNNB1 protein results in decreased susceptibility to bortezomib] | decreases reaction|decreases response to substance | 18485479
|
C400082 |
bortezomib |
bortezomib results in increased expression of CTNNB1 protein | increases expression | 18485479
|
C400082 |
bortezomib |
CTNNB1 protein results in decreased susceptibility to bortezomib | decreases response to substance | 18485479
|
C471992 |
bosutinib |
bosutinib affects the localization of CTNNB1 protein | affects localization | 16489032
|
C471992 |
bosutinib |
bosutinib inhibits the reaction [CTNNB1 protein binds to TCF4 protein] | affects binding|decreases reaction | 16489032
|
C471992 |
bosutinib |
bosutinib inhibits the reaction [SRC protein results in increased phosphorylation of CTNNB1 protein] | decreases reaction|increases phosphorylation | 16489032
|
C471992 |
bosutinib |
bosutinib promotes the reaction [CTNNB1 protein binds to CDH1 protein] | affects binding|increases reaction | 16489032
|
C471992 |
bosutinib |
bosutinib results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 16489032
|
C471992 |
bosutinib |
CTNNB1 protein promotes the reaction [bosutinib results in increased stability of CDH1 protein] | increases reaction|increases stability | 16489032
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 16272459
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein | affects cotreatment|increases expression | 16272459
|
D002087 |
Butyrates |
Butyrates results in decreased expression of CTNNB1 protein | decreases expression | 15177505
|
D002087 |
Butyrates |
[estradiol dipropionate co-treated with Butyrates] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 15930180
|
C055494 |
caffeic acid phenethyl ester |
caffeic acid phenethyl ester results in decreased expression of CTNNB1 protein | decreases expression | 10783313
|
C059041 |
calyculin A |
calyculin A results in increased phosphorylation of CTNNB1 protein | increases phosphorylation | 12813129
|
C095591 |
chan su |
chan su results in increased degradation of CTNNB1 protein | increases degradation | 16012733
|
D007631 |
Chlordecone |
Chlordecone results in decreased expression of CTNNB1 protein | decreases expression | 11695219
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of CTNNB1 mRNA | affects expression | 17602206
|
D003024 |
Clozapine |
Clozapine results in increased expression of CTNNB1 protein | increases expression | 16144542
|
D003024 |
Clozapine |
DRD2 protein affects the reaction [Clozapine results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D003407 |
Creosote |
Creosote affects the localization of CTNNB1 protein | affects localization | 12604173
|
D003474 |
Curcumin |
Curcumin analog results in decreased expression of CTNNB1 mRNA | decreases expression | 17041101
|
D003474 |
Curcumin |
Curcumin analog results in increased degradation of CTNNB1 protein | increases degradation | 17041101
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [CTNNB1 protein binds to TCF7L2 protein] | affects binding|decreases reaction | 19294764
|
D003474 |
Curcumin |
Curcumin results in decreased activity of [CTNNB1 protein binds to TCF7L2 protein] | affects binding|decreases activity | 19294764
|
D003474 |
Curcumin |
Curcumin results in decreased expression of CTNNB1 mRNA | decreases expression | 17041101
|
D003474 |
Curcumin |
Curcumin results in decreased expression of CTNNB1 protein | decreases expression | 19573523
|
D003474 |
Curcumin |
Curcumin results in increased degradation of CTNNB1 protein | increases degradation | 17041101
|
D003474 |
Curcumin |
Curcumin results in decreased expression of CTNNB1 protein | decreases expression | 10783313
|
D003474 |
Curcumin |
Curcumin results in decreased expression of CTNNB1 | decreases expression | 18462866
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of CTNNB1 mRNA | decreases expression | 20106945
|
C014347 |
decitabine |
CTNNB1 protein results in decreased susceptibility to decitabine | decreases response to substance | 19234609
|
C014347 |
decitabine |
decitabine affects the localization of CTNNB1 protein | affects localization | 19387464
|
C014347 |
decitabine |
decitabine results in increased expression of CTNNB1 protein | increases expression | 19234609
|
C014347 |
decitabine |
decitabine results in decreased expression of CTNNB1 mRNA | decreases expression | 19222872
|
D016264 |
Dextran Sulfate |
Dextran Sulfate results in increased expression of CTNNB1 protein | increases expression | 16049979
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of CTNNB1 protein | increases expression | 20074550
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of CTNNB1 protein | increases expression | 18978308
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MYC protein] | decreases reaction|increases expression | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of AKT1 protein] | decreases reaction|increases phosphorylation | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] | decreases reaction|increases phosphorylation | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of PDK1 protein] | decreases reaction|increases phosphorylation | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of EGFR protein] | decreases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of HGFAC protein] | decreases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of HGF protein] | decreases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of MET protein] | decreases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of FAS protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of NFKB1 protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of NFKBIA protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of RELA protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of TRAF1 protein] | increases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein results in decreased susceptibility to Diethylnitrosamine | decreases response to substance | 20583210
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of CTNNB1 protein | increases expression | 20583210
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of CTNNB1 protein | increases expression | 16439099
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of CTNNB1 mRNA | increases expression | 14648872
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [CTNNB1 protein binds to VDR protein] | affects binding|increases reaction | 16051482
|
D002117 |
Calcitriol |
Calcitriol results in decreased activity of CTNNB1 protein | decreases activity | 16051482
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in increased expression of CTNNB1 protein | increases expression | 20091315
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of CTNNB1 mRNA | decreases expression | 16968065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of CTNNB1 protein | decreases expression | 16968065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased localization of CTNNB1 protein | decreases localization | 16968065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 16968065
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in decreased expression of CTNNB1 protein | decreases expression | 12351151
|
D004958 |
Estradiol |
Estradiol results in increased expression of and affects the localization of CTNNB1 protein | affects localization|increases expression | 16053526
|
D004958 |
Estradiol |
Estradiol results in increased expression of CTNNB1 mRNA | increases expression | 14648872
|
D004958 |
Estradiol |
Estradiol affects the localization of CTNNB1 protein | affects localization | 17170212
|
D004958 |
Estradiol |
Estradiol promotes the reaction [CTNNB1 protein binds to LEF1 protein] | affects binding|increases reaction | 17170212
|
C023482 |
estradiol dipropionate |
[estradiol dipropionate co-treated with Butyrates] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 15930180
|
C023482 |
estradiol dipropionate |
[estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 15930180
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA | affects cotreatment|increases expression | 17942748
|
D005492 |
Folic Acid |
Folic Acid affects the expression of CTNNB1 mRNA | affects expression | 16361273
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of CTNNB1 mRNA | increases expression | 16221962
|
C001277 |
geldanamycin |
geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein] | affects binding|increases reaction | 17024233
|
C001277 |
geldanamycin |
IL24 protein promotes the reaction [geldanamycin promotes the reaction [CDH1 protein binds to CTNNB1 protein]] | affects binding|increases reaction | 17024233
|
D019833 |
Genistein |
[Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein | affects cotreatment|increases expression | 16443925
|
C007845 |
gingerol |
gingerol affects the localization of CTNNB1 protein | affects localization | 18058799
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of CTNNB1 mRNA | decreases expression | 18797397
|
D006220 |
Haloperidol |
DRD2 protein affects the reaction [Haloperidol results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of CTNNB1 protein | increases expression | 16144542
|
D006582 |
Hexachlorophene |
Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16735606
|
D006582 |
Hexachlorophene |
Hexachlorophene inhibits the reaction [WNT3A protein results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16735606
|
D006582 |
Hexachlorophene |
Hexachlorophene results in increased degradation of CTNNB1 protein | increases degradation | 16735606
|
D006582 |
Hexachlorophene |
SIAH1 protein promotes the reaction [Hexachlorophene results in increased degradation of CTNNB1 protein] | increases degradation|increases reaction | 16735606
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of CTNNB1 mRNA | decreases expression | 12419474
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of CTNNB1 protein | decreases expression | 16204253
|
D006861 |
Hydrogen Peroxide |
pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 16204253
|
D006861 |
Hydrogen Peroxide |
pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased stability of CTNNB1 protein] | decreases reaction|decreases stability | 16204253
|
D007213 |
Indomethacin |
Indomethacin affects the localization of CTNNB1 protein | affects localization | 15963497
|
D007213 |
Indomethacin |
Indomethacin inhibits the reaction [[CTNNB1 protein binds to TCF7L2 protein] which binds to CCND1 promoter] | affects binding|decreases reaction | 11756231
|
D007213 |
Indomethacin |
Indomethacin results in decreased expression of CTNNB1 mRNA | decreases expression | 11756231
|
D007213 |
Indomethacin |
Indomethacin results in decreased expression of CTNNB1 protein | decreases expression | 11756231 15188006
|
D007213 |
Indomethacin |
Indomethacin results in increased phosphorylation of CTNNB1 protein | increases phosphorylation | 12813129
|
D007213 |
Indomethacin |
lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 11756231
|
D007213 |
Indomethacin |
Lithium Chloride inhibits the reaction [Indomethacin results in increased phosphorylation of CTNNB1 protein] | decreases reaction|increases phosphorylation | 12813129
|
D007213 |
Indomethacin |
1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16818512
|
D007213 |
Indomethacin |
Indomethacin results in increased expression of CTNNB1 protein | increases expression | 16818512
|
D007213 |
Indomethacin |
nitroaspirin inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16818512
|
C067713 |
lactacystin |
lactacystin inhibits the reaction [Indomethacin results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 11756231
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CTNNB1 protein | increases expression | 11739494
|
D008094 |
Lithium |
Lithium results in increased expression of CTNNB1 protein | increases expression | 19621015
|
D008094 |
Lithium |
Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] | decreases reaction|increases expression | 19149911
|
D008094 |
Lithium |
Lithium results in decreased expression of CTNNB1 mRNA | decreases expression | 12942141
|
D008094 |
Lithium |
Lithium results in increased expression of and affects the localization of CTNNB1 protein | affects localization|increases expression | 16288908
|
D008094 |
Lithium |
Lithium results in increased expression of CTNNB1 protein | increases expression | 12942141
|
D018021 |
Lithium Chloride |
CTNNB1 protein affects the reaction [[Lithium Chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein] | affects reaction|decreases activity|decreases expression | 19274078
|
D018021 |
Lithium Chloride |
CTNNB1 protein promotes the reaction [Lithium Chloride results in increased expression of POU5F1 mRNA] | increases expression|increases reaction | 20074550
|
D018021 |
Lithium Chloride |
CTNNB1 protein promotes the reaction [Lithium Chloride results in increased expression of POU5F1 protein] | increases expression|increases reaction | 20074550
|
D018021 |
Lithium Chloride |
Hexachlorophene inhibits the reaction [Lithium Chloride results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16735606
|
D018021 |
Lithium Chloride |
Lithium Chloride inhibits the reaction [Aspirin results in increased phosphorylation of CTNNB1 protein] | decreases reaction|increases phosphorylation | 12813129
|
D018021 |
Lithium Chloride |
Lithium Chloride inhibits the reaction [Indomethacin results in increased phosphorylation of CTNNB1 protein] | decreases reaction|increases phosphorylation | 12813129
|
D018021 |
Lithium Chloride |
Lithium Chloride results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 16076840
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of and results in increased localization of CTNNB1 protein | increases expression|increases localization | 20074550 19679347
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of CTNNB1 mRNA | increases expression | 20069066
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of CTNNB1 protein | increases expression | 20069066 16735606 16053526
|
D018021 |
Lithium Chloride |
SFRP2 protein affects the reaction [Lithium Chloride results in increased expression of CTNNB1 mRNA] | affects reaction|increases expression | 20069066
|
D018021 |
Lithium Chloride |
Lithium Chloride promotes the reaction [CTNNB1 protein binds to GCG promoter] | affects binding|increases reaction | 19582394
|
D018021 |
Lithium Chloride |
Lithium Chloride promotes the reaction [CTNNB1 protein binds to GIP promoter] | affects binding|increases reaction | 19582394
|
D018021 |
Lithium Chloride |
Lithium Chloride promotes the reaction [[LEF1 protein co-treated with CTNNB1 protein] binds to GCG promoter] | affects binding|affects cotreatment|increases reaction | 19582394
|
D018021 |
Lithium Chloride |
Lithium Chloride promotes the reaction [[LEF1 protein co-treated with CTNNB1 protein] binds to GIP promoter] | affects binding|affects cotreatment|increases reaction | 19582394
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased activity of CTNNB1 protein | increases activity | 19582394
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of and affects the localization of CTNNB1 protein | affects localization|increases expression | 15364539
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased localization of CTNNB1 protein | increases localization | 19442631
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein | decreases activity|increases localization|increases phosphorylation | 19582394
|
D018021 |
Lithium Chloride |
[[Lithium Chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mRNA | decreases activity|increases expression|increases localization|increases phosphorylation | 19582394
|
D018021 |
Lithium Chloride |
[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein | decreases activity|increases expression | 18972237
|
D018021 |
Lithium Chloride |
[[Lithium Chloride results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein] which affects the expression of GJA1 protein | affects expression|decreases activity|increases expression | 18972237
|
D008345 |
Manganese |
Manganese results in decreased expression of CTNNB1 mRNA | decreases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of CTNNB1 mRNA | decreases expression | 17175027
|
D008694 |
Methamphetamine |
Lithium inhibits the reaction [Methamphetamine results in increased expression of CTNNB1 mRNA] | decreases reaction|increases expression | 19149911
|
D008694 |
Methamphetamine |
Methamphetamine results in increased expression of CTNNB1 mRNA | increases expression | 19149911
|
D008731 |
Methoxychlor |
[Genistein co-treated with Methoxychlor] results in increased expression of CTNNB1 protein | affects cotreatment|increases expression | 16443925
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased expression of CTNNB1 protein | increases expression | 12096346
|
D015741 |
Metribolone |
Metribolone promotes the reaction [NDRG1 protein binds to CTNNB1 protein] | affects binding|increases reaction | 17220478
|
C423917 |
MG 262 |
MG 262 inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17219422
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of CTNNB1 mRNA | increases expression | 17584828
|
D015735 |
Mifepristone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CTNNB1 mRNA] | decreases expression|decreases reaction | 17478549
|
D015735 |
Mifepristone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17478549
|
D009534 |
Niclosamide |
Niclosamide inhibits the reaction [WNT3A protein results in increased stability of CTNNB1 protein] | decreases reaction|increases stability | 19772353
|
C102148 |
nitroaspirin |
nitroaspirin inhibits the reaction [Indomethacin results in increased expression of CTNNB1 protein] | decreases reaction|increases expression | 16818512
|
D005996 |
Nitroglycerin |
4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] | decreases localization|decreases reaction | 17030184
|
D005996 |
Nitroglycerin |
4-(2-aminoethyl)benzenesulfonylfluoride inhibits the reaction [Nitroglycerin results in increased degradation of and results in decreased activity of CTNNB1 protein] | decreases activity|decreases reaction|increases degradation | 17030184
|
D005996 |
Nitroglycerin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Nitroglycerin results in increased degradation of CTNNB1 protein] | increases degradation|increases reaction | 17030184
|
D005996 |
Nitroglycerin |
Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein] | affects binding|decreases reaction | 17030184
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased localization of CTNNB1 protein | decreases localization | 17030184
|
D005996 |
Nitroglycerin |
Nitroglycerin results in decreased phosphorylation of and results in increased nitrosation of and results in increased degradation of and results in decreased activity of CTNNB1 protein | decreases activity|decreases phosphorylation|increases degradation|increases nitrosation | 17030184
|
D005996 |
Nitroglycerin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]] | affects binding|decreases reaction | 17030184
|
D005996 |
Nitroglycerin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] | decreases localization|decreases reaction | 17030184
|
D005996 |
Nitroglycerin |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin results in increased degradation of and results in decreased activity of CTNNB1 protein] | decreases activity|decreases reaction|increases degradation | 17030184
|
C044387 |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine |
[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein | affects cotreatment|increases cleavage | 16844947
|
C044387 |
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine |
Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947
|
C076029 |
olanzapine |
olanzapine results in decreased expression of CTNNB1 mRNA | decreases expression | 18797397
|
D010100 |
Oxygen |
Oxygen deficiency results in decreased expression of CTNNB1 mRNA | decreases expression | 17175027
|
D010100 |
Oxygen |
[Butylated Hydroxytoluene co-treated with Oxygen] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 16272459
|
D010100 |
Oxygen |
[Butylated Hydroxytoluene co-treated with Oxygen] results in increased expression of CTNNB1 protein | affects cotreatment|increases expression | 16272459
|
C031181 |
phenanthrene |
phenanthrene affects the localization of CTNNB1 protein | affects localization | 12604173
|
D010656 |
Phenylephrine |
Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] | affects binding|increases reaction | 19799869
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CTNNB1 mRNA | decreases expression | 18445702
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [APP protein results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 16204253
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 16204253
|
C006253 |
pirinixic acid |
pirinixic acid inhibits the reaction [Hydrogen Peroxide results in decreased stability of CTNNB1 protein] | decreases reaction|decreases stability | 16204253
|
D010936 |
Plant Extracts |
[Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 12351151
|
C025299 |
polyphenols |
polyphenols results in decreased expression of CTNNB1 mRNA | decreases expression | 16293270
|
D017035 |
Pravastatin |
Pravastatin affects the localization of CTNNB1 protein | affects localization | 17188708
|
D017035 |
Pravastatin |
[resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 17188708
|
D011374 |
Progesterone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CTNNB1 mRNA] | decreases expression|decreases reaction | 17478549
|
D011374 |
Progesterone |
Mifepristone inhibits the reaction [Progesterone results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17478549
|
D011374 |
Progesterone |
Progesterone results in decreased expression of CTNNB1 mRNA | decreases expression | 17478549
|
D011374 |
Progesterone |
Progesterone results in decreased expression of CTNNB1 protein | decreases expression | 17478549
|
D011374 |
Progesterone |
Progesterone results in increased expression of CTNNB1 protein | increases expression | 17170212
|
D011691 |
Puromycin |
Puromycin affects the localization of CTNNB1 protein | affects localization | 15673299
|
C008704 |
pyrithione |
[Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein | affects cotreatment|increases cleavage | 17098228
|
D011794 |
Quercetin |
Quercetin affects the expression of CTNNB1 protein | affects expression | 15670774
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [CTNNB1 protein binds to TCF4 protein] | affects binding|decreases reaction | 15670774
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [DEFA2 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
D011794 |
Quercetin |
Quercetin results in decreased activity of CTNNB1 protein | decreases activity | 19440933 15670774
|
D011794 |
Quercetin |
Quercetin results in decreased activity of CTNNB1 protein | decreases activity | 18624906
|
D020891 |
Raclopride |
DRD2 protein affects the reaction [Raclopride results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D020891 |
Raclopride |
Raclopride results in increased expression of CTNNB1 protein | increases expression | 16144542
|
C059514 |
resveratrol |
resveratrol affects the localization of CTNNB1 protein | affects localization | 17188708
|
C059514 |
resveratrol |
[resveratrol co-treated with Pravastatin] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 17188708
|
D018967 |
Risperidone |
DRD2 protein affects the reaction [Risperidone results in increased expression of CTNNB1 protein] | affects reaction|increases expression | 16144542
|
D018967 |
Risperidone |
Risperidone results in increased expression of CTNNB1 protein | increases expression | 16144542
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of CTNNB1 protein | increases expression | 19621015
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [DEFA1 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [DEFA2 protein results in decreased phosphorylation of and results in increased activity of CTNNB1 protein] | decreases phosphorylation|decreases reaction|increases activity | 19814765
|
C417521 |
SB 216763 |
SB 216763 results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 16968061 16968065
|
C417521 |
SB 216763 |
SB 216763 results in increased expression of CTNNB1 protein | increases expression | 16968061 16968065
|
C417521 |
SB 216763 |
SB 216763 results in increased localization of CTNNB1 protein | increases localization | 16968065
|
C417521 |
SB 216763 |
[SB 216763 results in decreased activity of GSK3B protein] which results in increased expression of CTNNB1 protein | decreases activity|increases expression | 19159680
|
C417521 |
SB 216763 |
SB 216763 results in decreased phosphorylation of CTNNB1 protein | decreases phosphorylation | 19448134
|
C417521 |
SB 216763 |
SB 216763 results in increased expression of and affects the localization of CTNNB1 protein | affects localization|increases expression | 16288908
|
C410733 |
scriptaid |
scriptaid affects the expression of CTNNB1 mRNA | affects expression | 18813790
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of CTNNB1 mRNA | decreases expression | 14713550
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of CTNNB1 protein | decreases expression | 14713550
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of CTNNB1 mRNA | affects expression | 16507464
|
D013467 |
Sulindac |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CCND1 protein] | affects reaction|decreases expression | 18291362
|
D013467 |
Sulindac |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of CDK4 protein] | affects reaction|decreases expression | 18291362
|
D013467 |
Sulindac |
CTNNB1 protein affects the reaction [Sulindac results in decreased expression of MYC protein] | affects reaction|decreases expression | 18291362
|
D013467 |
Sulindac |
Sulindac results in decreased activity of [LEF1 protein binds to CTNNB1 protein] | affects binding|decreases activity | 11751639
|
D013467 |
Sulindac |
Sulindac results in decreased expression of CTNNB1 protein | decreases expression | 18291362
|
D013467 |
Sulindac |
[Sulindac co-treated with Plant Extracts] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 12351151
|
D013467 |
Sulindac |
Sulindac results in decreased expression of CTNNB1 protein | decreases expression | 10223192
|
C452601 |
sulindac derivative IND 12 |
sulindac derivative IND 12 promotes the reaction [CDH1 protein binds to CTNNB1 protein] | affects binding|increases reaction | 11912145
|
C025462 |
sulindac sulfide |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfide results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 14555707
|
C025462 |
sulindac sulfide |
sulindac sulfide affects the localization of and results in decreased expression of CTNNB1 protein | affects localization|decreases expression | 15188006
|
C025462 |
sulindac sulfide |
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of CCND1 protein] | decreases reaction|increases expression | 14710233
|
C025462 |
sulindac sulfide |
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein] | decreases reaction|increases expression | 14710233
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of and results in decreased localization of CTNNB1 protein | decreases expression|decreases localization | 14710233
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of CTNNB1 protein | decreases expression | 14555707
|
C025463 |
sulindac sulfone |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulindac sulfone results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 14555707
|
C025463 |
sulindac sulfone |
sulindac sulfone results in decreased expression of CTNNB1 protein | decreases expression | 10910034 14555707 12392815
|
C025463 |
sulindac sulfone |
sulindac sulfone results in increased expression of CTNNB1 protein | increases expression | 11602670
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNB1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CTNNB1 mRNA | increases expression | 17586704
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin inhibits the reaction [CTNNB1 protein binds to TCF4 protein]] | affects binding|decreases reaction | 17030184
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin results in decreased localization of CTNNB1 protein] | decreases localization|decreases reaction | 17030184
|
D014108 |
Tosylphenylalanyl Chloromethyl Ketone |
Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Nitroglycerin results in increased degradation of and results in decreased activity of CTNNB1 protein] | decreases activity|decreases reaction|increases degradation | 17030184
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CTNNB1 protein | increases expression | 17219422
|
D014212 |
Tretinoin |
[Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 17170073
|
D014212 |
Tretinoin |
Tretinoin inhibits the reaction [Cholecalciferol results in increased expression of CTNNB1 mRNA] | decreases reaction|increases expression | 17170073
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of CTNNB1 protein | decreases expression | 17064353
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of CTNNB1 mRNA | increases expression | 16236135
|
C012589 |
trichostatin A |
[3-deazaneplanocin co-treated with trichostatin A] affects the expression of CTNNB1 protein | affects cotreatment|affects expression | 18538736
|
C012589 |
trichostatin A |
[estradiol dipropionate co-treated with trichostatin A] results in decreased expression of CTNNB1 protein | affects cotreatment|decreases expression | 15930180
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [arsenite affects the localization of CTNNB1 protein] | affects localization|decreases reaction | 17400267
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of CTNNB1 protein | increases expression | 12942141 20734317
|
C047426 |
venlafaxine |
venlafaxine results in increased expression of CTNNB1 protein | increases expression | 18511088
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CTNNB1 mRNA | affects expression | 19015723
|
D014801 |
Vitamin A |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17219422
|
D014801 |
Vitamin A |
MG 262 inhibits the reaction [Vitamin A results in decreased expression of CTNNB1 protein] | decreases expression|decreases reaction | 17219422
|
D014801 |
Vitamin A |
Vitamin A results in decreased expression of CTNNB1 protein | decreases expression | 17219422
|
D014801 |
Vitamin A |
Vitamin A results in increased ubiquitination of and results in increased degradation of CTNNB1 protein | increases degradation|increases ubiquitination | 17219422
|
D002762 |
Cholecalciferol |
BMP2 protein promotes the reaction [Cholecalciferol results in increased expression of CTNNB1 mRNA] | increases expression|increases reaction | 17170073
|
D002762 |
Cholecalciferol |
[Cholecalciferol co-treated with Tretinoin] affects the localization of CTNNB1 protein | affects cotreatment|affects localization | 17170073
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of CTNNB1 mRNA | increases expression | 17170073
|
D002762 |
Cholecalciferol |
Tretinoin inhibits the reaction [Cholecalciferol results in increased expression of CTNNB1 mRNA] | decreases reaction|increases expression | 17170073
|
C111237 |
vorinostat |
vorinostat results in increased expression of and results in increased activity of CTNNB1 protein | increases activity|increases expression | 17417771
|
C009687 |
wortmannin |
wortmannin results in decreased expression of CTNNB1 protein | decreases expression | 11739494
|
D015032 |
Zinc |
Zinc inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in increased cleavage of CTNNB1 protein] | affects cotreatment|decreases reaction|increases cleavage | 16844947
|
D015032 |
Zinc |
[Zinc co-treated with pyrithione] results in increased cleavage of CTNNB1 protein | affects cotreatment|increases cleavage | 17098228
|
D015054 |
Zymosan |
Zymosan results in increased expression of CTNNB1 protein | increases expression | 11739494
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Sulindac |
4.55 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
5.28 | 14514962 11752688 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
5.28 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
7.55 | 19490988 |
MESH:D000015 |
Abnormalities, Multiple |
|
Vitamin A |
7.55 | 10992263 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.63 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.00 | 17505938 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
4.47 | 16889938 17190629 17202136 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
13.69 | 15814532 17670903 12690470 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
13.69 | 16595132 16316344 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
13.69 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Sulindac |
13.69 | 7897758 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
14.77 | 21297076 20525806 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
14.77 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
14.77 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
14.77 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
1,4-phenylenebis(methylene)selenocyanate |
21.40 | 12844480 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
21.40 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
21.40 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
21.40 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
21.40 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
21.40 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Indomethacin |
21.40 | 16537180 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
21.40 | 15688392 15113128 |
MESH:D000230 |
Adenocarcinoma |
|
Sulindac |
21.40 | 11910360 |
MESH:D000236 |
Adenoma |
marker/mechanism |
|
| 10223192 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
18.09 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
18.09 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
18.09 | 16963246 |
MESH:D000236 |
Adenoma |
|
Indomethacin |
18.09 | 11497255 |
MESH:D000236 |
Adenoma |
|
resveratrol |
18.09 | 15688382 |
MESH:D000236 |
Adenoma |
|
Sulindac |
18.09 | 10223192 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.93 | 17162532 19061943 18056438 19052882 16434500 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.93 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.93 | 16835633 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Sulindac |
7.64 | 15623613 11874996 12394442 11535846 19003578 17611924 16460482 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
sulindac sulfone |
7.64 | 16150858 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.75 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
3.95 | 16712894 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.14 | 14617031 12649775 16160616 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.13 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
2.84 | 15955085 |
MESH:D016301 |
Alveolar Bone Loss |
|
Indomethacin |
4.42 | 17225004 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
23.04 | 17570602 14715435 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
23.04 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
23.04 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Indomethacin |
23.04 | 15579461 17627676 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
23.04 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Plant Extracts |
23.04 | 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
23.04 | 16183991 16162502 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
23.04 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
23.04 | 18759972 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
23.04 | 16410023 16580781 17119284 16325427 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.28 | 17688650 |
MESH:D019969 |
Amphetamine-Related Disorders |
|
Amphetamine |
5.12 | 16916582 15010207 16459022 18475255 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.59 | 15469931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.44 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
10.24 | 11748828 |
MESH:D000740 |
Anemia |
|
Vitamin A |
10.24 | 16960172 |
MESH:D000740 |
Anemia |
|
Zymosan |
10.24 | 18664788 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.39 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Vitamin A |
3.97 | 16960172 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.01 | 16916123 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
8.20 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
8.20 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
2.90 | 10982225 |
MESH:D000855 |
Anorexia |
|
Amphetamine |
4.18 | 12005258 12183048 16084549 16101753 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.13 | 20872349 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
6.27 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
6.27 | 19015723 |
MESH:D001014 |
Aortic Aneurysm |
|
Indomethacin |
3.95 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Indomethacin |
3.96 | 10388637 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.29 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
7.31 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
7.31 | 11256880 |
MESH:D018771 |
Arthralgia |
|
Indomethacin |
4.22 | 2160914 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
20.22 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Plant Extracts |
20.22 | 14686799 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
20.22 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tosylphenylalanyl Chloromethyl Ketone |
20.22 | 18706406 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
20.22 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
20.22 | 15188379 15944321 15142272 17659584 16872482 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
5.46 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Indomethacin |
5.46 | 11248219 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
5.46 | 16292516 |
MESH:D020817 |
Asperger Syndrome |
|
Risperidone |
4.67 | 16401163 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
7.94 | 16516891 |
MESH:D001249 |
Asthma |
|
Tretinoin |
7.94 | 16456186 |
MESH:D001249 |
Asthma |
|
Vitamin A |
7.94 | 16732791 |
MESH:D001249 |
Asthma |
|
Zinc |
7.94 | 17085522 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
3.90 | 20485159 12372130 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.04 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
10.48 | 17363696 16126721 16037261 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
10.48 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
10.48 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
10.48 | 17967414 16873680 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Risperidone |
4.10 | 18349709 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
3.41 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
3.41 | 21388746 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
3.41 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
3.41 | 17069543 18685284 |
MESH:D001321 |
Autistic Disorder |
|
Risperidone |
3.41 | 16730335 19368416 18278980 16239862 16601648 16379507 18349709 18026891 18775368 19013209 18080171 17069546 15492353 16948927 17019624 15543515 15994720 19232924 19154706 15930063 17929164 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
3.41 | 17507914 18396377 18316065 18985861 15238991 18940202 20603192 18775368 17157402 19460635 18558336 19232924 17688650 16609825 18177632 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
18.40 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
18.40 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
18.40 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
18.40 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.51 | 16935849 |
MESH:D001477 |
Bartter Syndrome |
|
Indomethacin |
4.07 | 10684365 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.07 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
8.84 | 19153942 20338123 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Risperidone |
8.84 | 19154706 18278980 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
8.84 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.02 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
15.02 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.02 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.02 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
2.84 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
5.76 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
5.76 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
3.94 | 14601052 |
MESH:D001913 |
Bowen's Disease |
|
Sulindac |
4.41 | 11207687 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
3.62 | 15306635 |
MESH:D001929 |
Brain Edema |
|
Ammonia |
16.20 | 19393034 11481608 20217200 |
MESH:D001929 |
Brain Edema |
|
Hexachlorophene |
16.20 | 10663390 |
MESH:D001929 |
Brain Edema |
|
Indomethacin |
16.20 | 11481608 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.39 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
8.02 | 15845082 15665606 15380490 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
8.02 | 17109824 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
16.72 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
Indomethacin |
16.72 | 12524144 |
MESH:D002545 |
Brain Ischemia |
|
Plant Extracts |
16.72 | 16041641 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
16.72 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
6.44 | 15481559 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
6.44 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 12165863 |
MESH:D001943 |
Breast Neoplasms |
|
2-methoxyestradiol |
21.87 | 18223236 15219808 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
21.87 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
21.87 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
21.87 | 19526202 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
21.87 | 19250217 16243823 18462866 18593918 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
21.87 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
21.87 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
21.87 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
21.87 | 17018787 12948864 14630087 19861407 16675129 17261762 18497071 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
21.87 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
21.87 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
gingerol |
21.87 | 17683926 |
MESH:D001943 |
Breast Neoplasms |
|
Indomethacin |
21.87 | 17401462 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
21.87 | 14633655 11306469 16253758 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
21.87 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
21.87 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
21.87 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
21.87 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Sulindac |
21.87 | 16642371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
21.87 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
21.87 | 16873071 16443354 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
21.87 | 16144943 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
4.12 | 12794006 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
9.93 | 16813970 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Vitamin A |
9.93 | 17426644 17377406 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.45 | 11589617 |
MESH:D002056 |
Burns |
|
Indomethacin |
3.79 | 10459503 |
MESH:D002057 |
Burns, Chemical |
|
Plant Extracts |
4.39 | 9625245 |
MESH:D002100 |
Cachexia |
|
Indomethacin |
4.07 | 15625704 11239499 16537180 15141370 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.59 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.53 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
5.71 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
5.71 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.21 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
33.73 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
33.73 | 17261273 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
33.73 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
33.73 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
33.73 | 11135700 14691202 15073043 16217749 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
33.73 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
33.73 | 16502159 19519916 18393292 16698587 19919837 19394651 19107877 19335982 16328049 3581430 20101231 11831363 3084413 20084675 16681979 18978308 20214788 18785209 10672840 17428255 16878318 16807293 17162532 16540662 20432363 20935162 19383236 18665156 20512989 20524982 16935385 18971187 18210153 16830150 20514400 21159647 18691550 17173139 10737359 16779866 16569478 19539802 18056438 19701751 19052882 20007298 20727157 18506893 18494052 19822196 17761372 19171122 19418558 16288022 17055752 17138121 18788625 17978847 19208518 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
33.73 | 16924424 15948411 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
33.73 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
33.73 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Indomethacin |
33.73 | 16391822 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Plant Extracts |
33.73 | 18834353 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
33.73 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
33.73 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
33.73 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
33.73 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Indomethacin |
8.34 | 11053908 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
8.34 | 16675471 |
MESH:D018276 |
Carcinoma, Medullary |
|
Indomethacin |
4.42 | 14736730 11352223 18791128 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
12.03 | 16052434 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
12.03 | 16685392 12023789 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
12.03 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
12.03 | 12391285 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfone |
12.03 | 18758305 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.04 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
3.92 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
4.79 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Indomethacin |
4.79 | 17341418 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.28 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
22.16 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
22.16 | 6189445 18337622 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
22.16 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
22.16 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Indomethacin |
22.16 | 12636206 15482327 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
22.16 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
22.16 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
22.16 | 16096774 16051514 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
22.16 | 16543248 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
11.31 | 15728586 16170337 11179087 17124262 11754973 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Plant Extracts |
11.31 | 17645561 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
11.31 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
11.31 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
15.28 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
15.28 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
15.28 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
15.28 | 15458977 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
15.28 | 16936243 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
3.98 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
8.71 | 10977129 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
8.71 | 12484553 |
MESH:D002386 |
Cataract |
|
Tretinoin |
8.71 | 17460283 |
MESH:D002389 |
Catatonia |
|
olanzapine |
5.30 | 18071103 16772815 |
MESH:D002430 |
Cecal Neoplasms |
marker/mechanism |
|
| 14688030 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
21.07 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
21.07 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
21.07 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
21.07 | 21159647 2727394 17174075 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
21.07 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
21.07 | 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
21.07 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
3.66 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.27 | 20734317 |
MESH:D015362 |
Child Nutrition Disorders |
|
Vitamin A |
4.53 | 16153327 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
6.62 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
6.62 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
Indomethacin |
4.22 | 11181007 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
17.46 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
17.46 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
17.46 | 16919318 17110522 16105132 17681005 15861022 11677210 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
17.46 | 19176532 |
MESH:D002779 |
Cholestasis |
|
Vitamin A |
17.46 | 16175620 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.21 | 16461808 |
MESH:D016770 |
Ciliophora Infections |
|
Niclosamide |
4.79 | 12113305 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.39 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
9.92 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
9.92 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
9.92 | 9407595 |
MESH:D002972 |
Cleft Palate |
|
Vitamin A |
9.92 | 16054864 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.05 | 17123785 |
MESH:D003092 |
Colitis |
|
Curcumin |
15.55 | 16804969 16782535 18200517 |
MESH:D003092 |
Colitis |
|
Dextran Sulfate |
15.55 | 15652231 16375993 18023891 12065299 |
MESH:D003092 |
Colitis |
|
resveratrol |
15.55 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
15.55 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
3.69 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester |
36.81 | 16818512 |
MESH:D003110 |
Colonic Neoplasms |
|
1,4-phenylenebis(methylene)selenocyanate |
36.81 | 10753194 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
36.81 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
36.81 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
36.81 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
36.81 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
36.81 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
36.81 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Indomethacin |
36.81 | 15637740 15786552 15936596 15625704 15963497 11260862 |
MESH:D003110 |
Colonic Neoplasms |
|
nitroaspirin |
36.81 | 16818512 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
36.81 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
36.81 | 19056647 16640504 17191121 19440933 11134977 17148506 15741050 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
36.81 | 16338953 |
MESH:D003110 |
Colonic Neoplasms |
|
Sulindac |
36.81 | 12458338 12902858 |
MESH:D003110 |
Colonic Neoplasms |
|
Vitamin A |
36.81 | 17219422 16267017 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
15.75 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
15.75 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
15.75 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
15.75 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
15.75 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
15.75 | 16985020 16963246 17116713 17087956 17245555 |
MESH:D015179 |
Colorectal Neoplasms |
|
Indomethacin |
15.75 | 17054584 18059344 12606626 11197048 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
15.75 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
15.75 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Sulindac |
15.75 | 11076880 18059344 11197048 10666051 |
MESH:D015179 |
Colorectal Neoplasms |
|
sulindac sulfone |
15.75 | 10666051 11197048 10416599 18059344 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.25 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
3.98 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.08 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.29 | 12609071 |
MESH:D018352 |
Coronavirus Infections |
|
Indomethacin |
4.77 | 17302372 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 11262227 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
8.78 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
8.78 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
8.78 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
8.78 | 9142499 10589399 16925845 17551590 8800419 9125849 14991402 9211117 9664655 9224671 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
8.78 | 8888407 17688650 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin A |
8.78 | 10992263 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
8.78 | 19302082 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
8.41 | 16002989 12952375 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
8.41 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.11 | 18551238 |
MESH:D003556 |
Cystitis |
|
Acrolein |
4.45 | 12161096 |
MESH:D007644 |
Darier Disease |
|
Lithium |
4.98 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
13.33 | 15213294 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
13.33 | 20210726 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Risperidone |
13.33 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
7.72 | 11575062 |
MESH:D003704 |
Dementia |
|
Risperidone |
7.72 | 11575062 |
MESH:D003866 |
Depressive Disorder |
|
venlafaxine |
4.11 | 20305041 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
4.66 | 12868966 11298694 8156756 8970840 18759878 11906362 2524372 14531868 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Ammonia |
4.66 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
1.89 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
2.63 | 3621924 2952479 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.00 | 17069543 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
4.83 | 19244398 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
6.88 | 17446233 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
6.88 | 16479319 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
5.93 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
5.93 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Vitamin A |
3.13 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
18.48 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
18.48 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
18.48 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
18.48 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
18.48 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
18.48 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
18.48 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
18.48 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
14.86 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.86 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Plant Extracts |
14.86 | 19706694 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
14.86 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.58 | 17187935 |
MESH:D003930 |
Diabetic Retinopathy |
|
Sulindac |
4.28 | 17621415 12861449 |
MESH:D003967 |
Diarrhea |
|
Indomethacin |
5.68 | 7237001 7907874 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
5.68 | 20479100 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
11.30 | 15331141 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Risperidone |
11.30 | 16379507 |
MESH:D053207 |
Diurnal Enuresis |
|
Risperidone |
5.72 | 17822346 |
MESH:D004314 |
Down Syndrome |
|
Risperidone |
4.34 | 18349709 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.71 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
17.71 | 16192314 6679447 18289764 11289319 7440962 18648102 1440618 9328219 9022650 6482804 18692083 9653073 8291058 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
17.71 | 14986274 11287661 11834606 19739265 19164858 10915739 16081117 16109766 2444490 15968718 19923254 17522070 16177239 17906064 16227642 11421492 19085960 12392966 12594235 19416960 19420014 12705907 15619225 16393943 12958197 11529661 18713872 16485898 10663392 12540782 17562736 18071297 11743745 11461765 10774834 14725611 11739529 12153990 16781746 19370779 14550746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.71 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
17.71 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
17.71 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
17.71 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.71 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
17.71 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.15 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
5.71 | 15033597 12649298 19839026 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
5.71 | 11462148 |
MESH:D015352 |
Dry Eye Syndromes |
|
Vitamin A |
4.87 | 16146918 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Indomethacin |
4.22 | 17190690 16326151 12774134 18043480 16133044 18446180 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
6.49 | 17351913 |
MESH:D004381 |
Duodenal Ulcer |
|
Indomethacin |
6.49 | 17045617 17151854 10671773 17329845 11595431 11991626 16699067 11535926 17202747 17351913 11595415 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
3.46 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
3.90 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.18 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin A |
4.67 | 9068938 |
MESH:D004480 |
Ectromelia |
|
Vitamin A |
4.87 | 16054864 |
MESH:D004487 |
Edema |
|
Aspirin |
23.70 | 17259670 |
MESH:D004487 |
Edema |
|
Indomethacin |
23.70 | 7907874 8273558 16100529 19703484 8985016 10653021 7990266 |
MESH:D004487 |
Edema |
|
pirinixic acid |
23.70 | 12083418 |
MESH:D004487 |
Edema |
|
Plant Extracts |
23.70 | 12787963 |
MESH:D004487 |
Edema |
|
resveratrol |
23.70 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
23.70 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
23.70 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Zymosan |
23.70 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
8.80 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
8.80 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
14.72 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.72 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.72 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
14.72 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
10.88 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
10.88 | 19294695 |
MESH:D018159 |
Endolymphatic Hydrops |
|
Dimethyl Sulfoxide |
5.61 | 20641076 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
8.80 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
8.80 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
16.14 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.14 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
16.14 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.14 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.14 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Indomethacin |
19.90 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
19.90 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
19.90 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Sulindac |
19.90 | 15652904 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
19.90 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Plant Extracts |
4.73 | 15268973 |
MESH:D019446 |
Endotoxemia |
|
Indomethacin |
7.58 | 18509659 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
7.58 | 15821434 17637181 15328337 |
MESH:D004751 |
Enteritis |
|
Indomethacin |
3.80 | 17763956 10567023 16328016 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
Indomethacin |
9.34 | 17980183 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
9.34 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Indomethacin |
3.17 | 11298111 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.24 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
2.98 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Plant Extracts |
5.03 | 19439326 19700373 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
2.78 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.38 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.14 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.17 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.61 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
12.61 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
12.61 | 16785472 16481741 17638652 15173087 15464296 |
MESH:D004938 |
Esophageal Neoplasms |
|
Indomethacin |
12.61 | 11005569 |
MESH:D004938 |
Esophageal Neoplasms |
|
Sulindac |
12.61 | 12235107 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
12.61 | 16543248 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
4.56 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
6.34 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
6.34 | 16938888 9664655 |
MESH:D005221 |
Fatigue |
|
Amphetamine |
9.51 | 19890266 |
MESH:D005221 |
Fatigue |
|
vorinostat |
9.51 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
38.01 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
38.01 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
38.01 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
38.01 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
38.01 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
38.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
38.01 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Plant Extracts |
38.01 | 15975614 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
38.01 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
38.01 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.00 | 16002989 16513791 15751030 16534752 16611131 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.55 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
3.94 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.24 | 8888407 18558336 |
MESH:D005327 |
Fetal Resorption |
|
Vitamin A |
4.42 | 16054864 |
MESH:D005334 |
Fever |
|
Indomethacin |
6.60 | 10431976 11852909 17627676 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
6.60 | 9205823 11852909 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.07 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Sulindac |
4.54 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Sulindac |
4.20 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Indomethacin |
9.12 | 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
9.12 | 11555667 |
MESH:D005355 |
Fibrosis |
|
arsenite |
27.79 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
27.79 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
27.79 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Indomethacin |
27.79 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
27.79 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
27.79 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
27.79 | 17994277 |
MESH:D005393 |
Fish Diseases |
|
Niclosamide |
4.76 | 12113305 |
MESH:D005499 |
Folliculitis |
|
Indomethacin |
4.22 | 11298111 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.37 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.27 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
19.65 | 16983495 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
19.65 | 17171786 |
MESH:D005756 |
Gastritis |
|
Indomethacin |
19.65 | 15046732 |
MESH:D005756 |
Gastritis |
|
Zinc |
19.65 | 17241300 |
MESH:D005764 |
Gastroesophageal Reflux |
|
Sulindac |
4.12 | 11910360 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
3.78 | 18462866 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.00 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.35 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
9.72 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
9.72 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.29 | 8708960 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.20 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
27.35 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
27.35 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
27.35 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Indomethacin |
27.35 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
27.35 | 17043766 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
27.35 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
27.35 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
27.35 | 18801729 |
MESH:D005910 |
Glioma |
|
Indomethacin |
7.22 | 16487511 18371953 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
7.22 | 9825942 |
MESH:D005910 |
Glioma |
|
Quercetin |
7.22 | 17643826 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
Indomethacin |
3.50 | 11849393 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.20 | 19446573 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.16 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.64 | 10696789 |
MESH:D006073 |
Gout |
|
Indomethacin |
4.42 | 11248219 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
3.29 | 17217573 |
MESH:D006261 |
Headache |
|
Aspirin |
8.16 | 15240983 |
MESH:D006261 |
Headache |
|
Nitroglycerin |
8.16 | 11284996 11554966 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
16.83 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
16.83 | 18462866 18829502 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
16.83 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Indomethacin |
16.83 | 15482327 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
16.83 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
7.69 | 19898482 |
MESH:D034381 |
Hearing Loss |
|
Dimethyl Sulfoxide |
7.69 | 20641076 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.21 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.62 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
14.78 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
14.78 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
14.78 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
14.78 | 9664655 14991402 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin A |
14.78 | 10992263 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
8.13 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Plant Extracts |
8.13 | 18097624 |
MESH:D006333 |
Heart Failure |
|
Zinc |
8.13 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
4.82 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
3.66 | 17241300 |
MESH:D006394 |
Hemangiosarcoma |
marker/mechanism |
|
| 13678655 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.49 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.55 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Ammonia |
8.56 | 20549931 16338762 12420312 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Indomethacin |
8.56 | 15633222 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
6.69 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
6.69 | 19110552 |
MESH:D019698 |
Hepatitis C, Chronic |
|
Indomethacin |
3.79 | 15135802 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
3.78 | 17276780 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
9.28 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.28 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.28 | 15340226 16120746 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.12 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin A |
3.19 | 16863852 16490937 16877224 16292552 17436238 15707848 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.08 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Plant Extracts |
7.05 | 10715843 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
7.05 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Plant Extracts |
5.19 | 12878215 |
MESH:D015658 |
HIV Infections |
|
Vitamin A |
5.19 | 16960176 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
10.26 | 17209195 |
MESH:D006679 |
HIV Seropositivity |
|
Vitamin A |
10.26 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
4.91 | 16170182 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
4.91 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
11.92 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Plant Extracts |
11.92 | 17454163 16566672 14716179 |
MESH:D019584 |
Hot Flashes |
|
venlafaxine |
11.92 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
3.93 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
9.88 | 19797860 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
9.88 | 18606429 16354765 16959395 8697196 15340226 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
4.81 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
12.38 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Indomethacin |
12.38 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
12.38 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
12.38 | 16870215 |
MESH:D034321 |
Hyperamylasemia |
|
Indomethacin |
4.77 | 17883296 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
4.60 | 18089816 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
10.72 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
Pravastatin |
10.72 | 17188708 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
10.72 | 17188708 |
MESH:D006940 |
Hyperemia |
|
Indomethacin |
4.07 | 12524144 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.65 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
11.03 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
11.03 | 11834736 18262572 |
MESH:D006943 |
Hyperglycemia |
|
Risperidone |
11.03 | 18278980 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
7.05 | 16397167 16395265 16865747 16433478 16755160 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Plant Extracts |
7.05 | 16484555 |
MESH:D006948 |
Hyperkinesis |
|
Amphetamine |
13.97 | 1977408 14960337 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
13.97 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
13.97 | 17658665 |
MESH:D006949 |
Hyperlipidemias |
|
Indomethacin |
10.63 | 17546600 |
MESH:D006949 |
Hyperlipidemias |
|
Plant Extracts |
10.63 | 15975614 15268973 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
10.63 | 16873680 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
5.29 | 17933447 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
7.81 | 15034207 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
7.81 | 14722030 12960047 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.69 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.43 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
8.43 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Quercetin |
8.43 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.43 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
3.70 | 12791704 18502941 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.47 | 17488730 |
MESH:D006986 |
Hypervitaminosis A |
|
Vitamin A |
5.22 | 16054864 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
8.22 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
8.22 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
Indomethacin |
4.08 | 10574470 18306037 |
MESH:D007079 |
Ileitis |
|
Indomethacin |
4.42 | 10651667 10647630 16133968 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Indomethacin |
4.42 | 16133044 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
8.46 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
8.46 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.46 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.59 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
17.46 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
17.46 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methoxychlor |
17.46 | 16467254 11955947 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
17.46 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
17.46 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
17.46 | 16467254 |
MESH:D007249 |
Inflammation |
|
Curcumin |
31.73 | 17151092 18403477 16956363 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
31.73 | 18785209 |
MESH:D007249 |
Inflammation |
|
Indomethacin |
31.73 | 3291741 12568917 7812673 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
31.73 | 12878042 17963957 17237260 17255318 9205823 |
MESH:D007249 |
Inflammation |
|
Plant Extracts |
31.73 | 12787963 15997105 19332304 16366677 |
MESH:D007249 |
Inflammation |
|
polyphenols |
31.73 | 16366677 |
MESH:D007249 |
Inflammation |
|
Progesterone |
31.73 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
31.73 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
31.73 | 12083418 |
MESH:D007249 |
Inflammation |
|
Sulindac |
31.73 | 3291741 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
31.73 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
31.73 | 11289658 8014878 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
5.43 | 18200517 18596194 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Dextran Sulfate |
5.43 | 15339030 20423518 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
8.06 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
8.06 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
8.41 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
8.41 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
8.41 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Indomethacin |
6.88 | 11855677 17329856 17994277 15831440 11686837 18236018 15610444 11713966 10210152 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
6.88 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
marker/mechanism |
|
| 10223192 |
MESH:D007414 |
Intestinal Neoplasms |
|
1,4-phenylenebis(methylene)selenocyanate |
21.82 | 10753194 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
21.82 | 10783313 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
21.82 | 10783313 |
MESH:D007414 |
Intestinal Neoplasms |
|
Plant Extracts |
21.82 | 12351151 12628509 12584176 |
MESH:D007414 |
Intestinal Neoplasms |
|
Sulindac |
21.82 | 10213222 10223192 12628509 12663524 12351151 12584176 |
MESH:D007417 |
Intestinal Polyps |
|
Sulindac |
4.11 | 11245490 12394442 |
MESH:D019586 |
Intracranial Hypertension |
|
Indomethacin |
11.04 | 15241188 |
MESH:D019586 |
Intracranial Hypertension |
|
Vitamin A |
11.04 | 15955940 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
3.76 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
4.90 | 17553498 |
MESH:D007511 |
Ischemia |
|
Zinc |
3.72 | 16584753 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.07 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
7.10 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
7.10 | 17551590 15992940 |
MESH:D007579 |
Jejunal Diseases |
|
Indomethacin |
4.08 | 18306037 10574470 16133968 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.04 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.49 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.19 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
30.68 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
30.68 | 12488133 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
30.68 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
30.68 | 12649298 12231392 18289764 19839026 15190930 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
30.68 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
30.68 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Indomethacin |
30.68 | 17190690 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
30.68 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
30.68 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
30.68 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
7.40 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
7.40 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
15.06 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.06 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.06 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
15.06 | 16762066 14681315 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.06 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
3.85 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.16 | 17184923 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
3.70 | 18555241 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Indomethacin |
3.12 | 12228301 11703811 10320625 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
20.98 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
20.98 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
20.98 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
20.98 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
20.98 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
20.98 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
20.98 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
(2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid |
16.36 | 16546985 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
16.36 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
16.36 | 18089816 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
16.36 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.38 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
6.08 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Indomethacin |
6.08 | 15631656 10785260 16572323 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
11.10 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
11.10 | 17236224 18454857 19117987 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
11.10 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
13.60 | 16968895 20471514 19850784 17050201 16467208 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
13.60 | 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
13.60 | 18460780 19387464 17679729 18704418 19010910 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Indomethacin |
13.60 | 18360721 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
13.60 | 16294345 17596541 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
13.60 | 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
13.60 | 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.51 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
12.59 | 17217047 16966277 12018890 15622746 16112521 17869043 19035177 19225113 11468182 19075265 17107899 15336539 9834237 12679006 16891316 16330433 15213294 16331271 19642359 11161223 17649720 15748426 12712474 16823087 17712046 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
12.59 | 16766008 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
12.59 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
12.59 | 19075265 17649720 17339181 17217047 16823087 17506722 16788101 17301526 17107899 19029980 17294898 16935935 19642359 17361223 17712046 16891316 16331271 16140955 19035177 12679006 16766008 19225113 15748426 17368321 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
8.75 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
8.75 | 16106398 |
MESH:D007964 |
Leukocytosis |
|
Indomethacin |
4.42 | 16537180 |
MESH:D007969 |
Leukomalacia, Periventricular |
|
Indomethacin |
4.77 | 17980183 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
3.77 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
3.80 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
9.67 | 15526292 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
9.67 | 9224671 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Vitamin A |
9.67 | 16054864 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.25 | 17567588 |
MESH:D008101 |
Liver Abscess, Amebic |
|
Indomethacin |
4.77 | 11479899 |
MESH:D008103 |
Liver Cirrhosis |
marker/mechanism |
|
| 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
10.83 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
10.83 | 20032147 18407596 18665156 18522880 19638242 |
MESH:D008103 |
Liver Cirrhosis |
|
Plant Extracts |
10.83 | 17157831 |
MESH:D008103 |
Liver Cirrhosis |
|
Vitamin A |
10.83 | 16256175 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
6.28 | 15034207 9327722 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
Sulindac |
6.28 | 12468960 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
22.51 | 18705752 17355460 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethyl Sulfoxide |
22.51 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
22.51 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
22.51 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
22.51 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Indomethacin |
22.51 | 18194892 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
22.51 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
22.51 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Plant Extracts |
22.51 | 15479170 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
22.51 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
22.51 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
22.51 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
22.51 | 16248980 18397230 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin A |
22.51 | 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
16.41 | 12969438 11587558 19014921 19460945 19784758 16611625 12587719 16610002 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
16.41 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
16.41 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
16.41 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Plant Extracts |
16.41 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
16.41 | 16698588 |
MESH:D008107 |
Liver Diseases |
|
Sulindac |
16.41 | 14986274 16867024 |
MESH:D008107 |
Liver Diseases |
|
Vitamin A |
16.41 | 16175620 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Vitamin A |
4.24 | 16762690 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.27 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
venlafaxine |
7.27 | 19857765 |
MESH:D008113 |
Liver Neoplasms |
marker/mechanism |
|
| 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
30.44 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
30.44 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
30.44 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
30.44 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
30.44 | 20405173 21278145 2862719 19690152 21071580 19499222 21167192 12112319 19642983 19073162 21047994 20137499 9163691 19638242 19256749 16942905 2422723 12771043 19090486 19427195 19255062 19426721 19996281 19833225 10737359 19551842 20492335 19294768 20583210 19812893 19254457 18648771 18978307 20118626 18754104 15885732 19850985 18644402 18977376 15175105 20501860 20101389 20434301 20452335 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
30.44 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
30.44 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Plant Extracts |
30.44 | 19168119 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
30.44 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
30.44 | 19073162 19812893 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
30.44 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
30.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
18.20 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
18.20 | 6587162 3712494 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
18.20 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
18.20 | 19126423 19009564 18093689 16267830 18164116 19539802 18253720 21159647 9362446 18775883 17942915 19004024 16842330 18544905 17854601 2563599 18308698 17174075 3124819 18079962 19519916 18282651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
18.20 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
18.20 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Vitamin A |
18.20 | 17113696 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
6.10 | 15213294 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
6.10 | 20210726 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.55 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
8.57 | 11504702 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
8.57 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin A |
8.57 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.32 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
10.13 | 17365036 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
10.13 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
10.13 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 18372914 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
19.75 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
19.75 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
19.75 | 19925653 11246140 18597497 19359593 11696405 15390079 16337739 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
19.75 | 17225452 6189445 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
19.75 | 19359593 18462866 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
19.75 | 6695378 20970405 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Indomethacin |
19.75 | 11053908 11497255 16537180 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
19.75 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Plant Extracts |
19.75 | 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
19.75 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
19.75 | 15276417 16712894 17077188 19931552 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Sulindac |
19.75 | 15713900 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
19.75 | 11884234 19555203 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
2.98 | 17718048 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.21 | 15166399 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
15.85 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
15.85 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
15.85 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
15.85 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
15.85 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
12.38 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
12.38 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
12.38 | 17088997 |
MESH:D020522 |
Lymphoma, Mantle-Cell |
marker/mechanism |
|
| 18787224 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.08 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
3.78 | 16173963 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
4.77 | 20479100 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.56 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.33 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
1,4-phenylenebis(methylene)selenocyanate |
25.42 | 12844480 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
25.42 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
25.42 | 11807958 17203775 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
25.42 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
25.42 | 15113128 17131329 15313902 10838139 11807958 17020996 11751437 15688392 16619500 14633655 10767621 16827153 16944150 12931682 19196723 16051031 14999141 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
25.42 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
25.42 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
25.42 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
25.42 | 12773700 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
9.86 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
9.86 | 16551646 16568477 19453300 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
4.76 | 16832597 |
MESH:D008527 |
Medulloblastoma |
marker/mechanism |
|
| |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
5.26 | 19213072 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
5.26 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
15.85 | 16248763 18332650 12374674 11135225 16809738 15577323 18505091 12883367 16432458 12393984 17023156 18176117 17761969 |
MESH:D008545 |
Melanoma |
|
Curcumin |
15.85 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
decitabine |
15.85 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
15.85 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
15.85 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
15.85 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Sulindac |
15.85 | 16642371 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
15.85 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
15.85 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
3.84 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
7.96 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
7.96 | 10803710 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.27 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.51 | 16940565 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
14.93 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
14.93 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
14.93 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Risperidone |
14.93 | 16856516 16596465 |
MESH:D001523 |
Mental Disorders |
|
venlafaxine |
14.93 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Risperidone |
3.69 | 18349709 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
4.86 | 16966607 16166281 18303189 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
4.86 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
8.17 | 19142110 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
8.17 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
11.58 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
Risperidone |
11.58 | 19142101 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
11.58 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
3.84 | 16801185 |
MESH:D008708 |
Methemoglobinemia |
|
Nitroglycerin |
3.88 | 3537620 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
12.07 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Indomethacin |
12.07 | 11903285 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
12.07 | 18765137 18803445 |
MESH:D008881 |
Migraine Disorders |
|
venlafaxine |
12.07 | 18803445 |
MESH:D020326 |
Migraine without Aura |
|
Nitroglycerin |
4.24 | 14659530 |
MESH:D019964 |
Mood Disorders |
|
Risperidone |
4.92 | 17019624 |
MESH:D019957 |
Motor Skills Disorders |
|
Hexachlorophene |
5.72 | 10663390 |
MESH:D009062 |
Mouth Neoplasms |
|
Indomethacin |
3.23 | 12636206 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.14 | 16551646 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
23.07 | 15949261 19417148 14977855 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
23.07 | 19372569 19112201 19112817 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
23.07 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
23.07 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
23.07 | 17164350 16267019 16490592 14749477 17049120 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
23.07 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Vitamin A |
23.07 | 16374440 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.34 | 18160304 12879239 15241586 15259001 10479408 15834315 12130978 17724436 15213630 10890648 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
15.79 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
15.79 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
15.79 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.60 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
7.85 | 18186108 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
7.85 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.72 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
12.40 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
12.40 | 18608210 16882708 19157545 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
12.40 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
12.40 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
26.84 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
26.84 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
26.84 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
Nitroglycerin |
26.84 | 14729435 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
26.84 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Pravastatin |
26.84 | 17188708 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
26.84 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
26.84 | 16525036 16456233 17188708 16317513 17125593 17015251 |
MESH:D009203 |
Myocardial Infarction |
|
SB 216763 |
26.84 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
6.42 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
6.42 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
14.08 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
14.08 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
14.08 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
14.08 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
3.83 | 17322642 |
MESH:D009325 |
Nausea |
|
Aspirin |
9.08 | 15240983 |
MESH:D009325 |
Nausea |
|
vorinostat |
9.08 | 20479100 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
2.94 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
7.37 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
7.37 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
6.65 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
6.65 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Indomethacin |
6.65 | 11053908 11239499 16537180 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
21.59 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
21.59 | 16773208 |
MESH:D009369 |
Neoplasms |
|
decitabine |
21.59 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
21.59 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
21.59 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
21.59 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
21.59 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
21.59 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
21.59 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
Indomethacin |
14.43 | 15625704 10663608 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
14.43 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
14.43 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
14.43 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
3.59 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
7.08 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
7.08 | 17289903 |
MESH:D009393 |
Nephritis |
|
Acrolein |
5.34 | 12653641 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.55 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.49 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.47 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
3.52 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
21.42 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
21.42 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
21.42 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
21.42 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
21.42 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
4.68 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
28.22 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
28.22 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
28.22 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
28.22 | 10525206 19446573 18186108 11749123 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
28.22 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
28.22 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
28.22 | 16359493 8888407 |
MESH:D009436 |
Neural Tube Defects |
|
Vitamin A |
28.22 | 17400914 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
4.55 | 11555667 |
MESH:D019954 |
Neurobehavioral Manifestations |
|
Plant Extracts |
4.27 | 17168769 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
2.88 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
27.44 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
27.44 | 11342003 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Amphetamine |
27.44 | 15183010 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
27.44 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Indomethacin |
27.44 | 12349958 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
27.44 | 17652729 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Sulindac |
27.44 | 17266991 16850258 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
3.77 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
7.80 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
7.80 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.17 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
3.65 | 16322990 |
MESH:D053206 |
Nocturnal Enuresis |
|
Risperidone |
5.38 | 17822346 |
MESH:D009765 |
Obesity |
|
Clozapine |
10.31 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Curcumin |
10.31 | 19297423 |
MESH:D009765 |
Obesity |
|
olanzapine |
10.31 | 18515891 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
10.31 | 20558911 |
MESH:D009765 |
Obesity |
|
Plant Extracts |
10.31 | 19056576 20132043 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
venlafaxine |
4.81 | 17503984 |
MESH:D007752 |
Obstetric Labor, Premature |
|
Indomethacin |
4.22 | 6374098 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.13 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
6.13 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.07 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
5.85 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
Indomethacin |
5.85 | 7009135 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
5.17 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
5.17 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
11.88 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
11.88 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
11.88 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
37.61 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
37.61 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
37.61 | 17225452 19769630 15464296 6897625 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
37.61 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
37.61 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
37.61 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
37.61 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
37.61 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
37.61 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
37.61 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
37.61 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
37.61 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
37.61 | 19331143 |
MESH:D010146 |
Pain |
|
Acetaminophen |
13.01 | 16870215 |
MESH:D010146 |
Pain |
|
Aspirin |
13.01 | 6363464 6995502 |
MESH:D010146 |
Pain |
|
Indomethacin |
13.01 | 17440234 17627676 3291741 13679232 |
MESH:D010146 |
Pain |
|
Sulindac |
13.01 | 3291741 |
MESH:D010146 |
Pain |
|
Tretinoin |
13.01 | 16870215 |
MESH:D010149 |
Pain, Postoperative |
|
Indomethacin |
3.74 | 18702446 12538197 |
MESH:D010190 |
Pancreatic Neoplasms |
marker/mechanism |
|
| 18223216 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
28.47 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
28.47 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
28.47 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
28.47 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
28.47 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
28.47 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
28.47 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Sulindac |
28.47 | 11504793 16820089 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
28.47 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
28.47 | 19294695 |
MESH:D010195 |
Pancreatitis |
|
Indomethacin |
3.08 | 15028970 17883296 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
2.81 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
10.44 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
10.44 | 12065085 |
MESH:D010212 |
Papilloma |
|
Plant Extracts |
10.44 | 16517061 15173996 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.29 | 19927285 |
MESH:D010257 |
Paraneoplastic Syndromes |
|
Indomethacin |
4.77 | 16537180 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
4.47 | 17690948 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
4.47 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Indomethacin |
10.84 | 12349958 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
10.84 | 16140633 |
MESH:D020734 |
Parkinsonian Disorders |
|
Raclopride |
10.84 | 12476322 |
MESH:D051302 |
Paroxysmal Hemicrania |
|
Indomethacin |
4.77 | 11903285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.30 | 12520081 |
MESH:D010437 |
Peptic Ulcer |
|
Indomethacin |
4.22 | 11148446 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
4.61 | 11156591 |
MESH:D010518 |
Periodontitis |
|
Indomethacin |
3.97 | 17225004 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.42 | 15464296 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
3.98 | 18557954 19641140 17371808 15259001 18760300 19088179 11985352 18977430 15979727 17826846 14761945 |
MESH:D020795 |
Photophobia |
|
Aspirin |
4.81 | 15240983 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
17.10 | 6228378 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
17.10 | 11550810 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
17.10 | 11550810 |
MESH:D018296 |
Pilomatrixoma |
marker/mechanism |
|
| |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.22 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
3.76 | 15687265 16977796 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
3.98 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
4.39 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
8.30 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
8.30 | 12224865 11605937 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
5.06 | 19692487 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.67 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
10.63 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
10.63 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
10.63 | 19056647 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
3.41 | 17114810 |
MESH:D047928 |
Premature Birth |
|
Indomethacin |
4.21 | 17000239 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
20.75 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
20.75 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
20.75 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
20.75 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
20.75 | 18042343 18220299 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
9.40 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
9.40 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.00 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
3.85 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.03 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17363566 |
MESH:D011471 |
Prostatic Neoplasms |
|
2-methoxyestradiol |
7.88 | 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
7.88 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
7.88 | 16644109 16289102 12479363 15754350 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
7.88 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
7.88 | 18156803 10851300 12497104 11398177 15129424 18769126 18226269 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
7.88 | 17136230 15046698 15846301 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
7.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
7.88 | 16925846 15256057 15378649 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
7.88 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
Plant Extracts |
7.88 | 14666653 17804756 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
7.88 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
7.88 | 17675339 16731767 17718901 15767336 17804756 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
7.88 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
sulindac sulfone |
7.88 | 17908994 15570007 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
7.88 | 18798265 19789329 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
7.88 | 17218635 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
7.88 | 16700911 16517595 16606632 12429649 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.00 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Indomethacin |
6.46 | 11849393 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
6.46 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.40 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
3.59 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
1.80 | 16882103 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
8.79 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
8.79 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
6.72 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
6.72 | 11575062 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
3.86 | 16723453 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
3.69 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.58 | 17365031 17322281 17975199 15814490 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
12.13 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
12.13 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
12.13 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.63 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
4.68 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
4.68 | 17058453 16314181 15827377 16317513 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
6.62 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
6.62 | 18339021 17627322 |
MESH:D012127 |
Respiratory Distress Syndrome, Newborn |
|
Vitamin A |
4.87 | 16877224 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.05 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
2.94 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
10.73 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
10.73 | 18172121 18155124 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
10.73 | 16584753 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.55 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
13.49 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
13.49 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
13.49 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
3.56 | 12372130 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.42 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.29 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
7.39 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
7.39 | 14601052 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.59 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
10.10 | 20107430 11763009 20521326 20521320 17726453 17667964 20452607 11151749 18855531 17123785 19369910 16141801 20168265 18806925 20580759 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
10.10 | 16641680 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
10.10 | 20107430 19369910 1830565 18513383 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
10.10 | 17726453 20521326 20107430 |
MESH:D012559 |
Schizophrenia |
|
Risperidone |
10.10 | 18278980 19154706 20107430 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
10.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.03 | 18551238 |
MESH:D012640 |
Seizures |
|
Lithium |
6.03 | 19660546 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.03 | 11738929 17978042 16876388 3137016 11044598 15475178 1511512 14763951 |
MESH:D018805 |
Sepsis |
|
Curcumin |
7.04 | 18389075 |
MESH:D018805 |
Sepsis |
|
Zymosan |
7.04 | 11441115 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
3.78 | 7327846 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
4.35 | 12269725 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
4.35 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Vitamin A |
4.35 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
gingerol |
18.76 | 19481070 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
18.76 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Plant Extracts |
18.76 | 15173996 16517061 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
18.76 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
18.76 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
18.76 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
18.76 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Risperidone |
4.58 | 18278980 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.39 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
8.57 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
8.57 | 16709447 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
4.56 | 16361298 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.35 | 16503802 15862959 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
7.00 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
7.00 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
9.52 | 19951488 19430551 19570321 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
9.52 | 12833885 |
MESH:D019956 |
Stereotypic Movement Disorder |
|
Amphetamine |
5.47 | 1977408 |
MESH:D013272 |
Stomach Diseases |
|
Indomethacin |
3.50 | 17638125 17160473 18545984 15472012 18209964 17207306 10192188 15038085 10486359 16113693 16280098 10215738 16184426 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
9.38 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
9.38 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
9.38 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
9.38 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
9.38 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Indomethacin |
9.38 | 15609394 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
9.38 | 18593901 15930296 16257854 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
9.38 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
7.45 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Indomethacin |
7.45 | 17135157 15138204 11729361 17895592 12467913 10423059 14567935 10878458 18087811 1323529 10750652 11595431 16150113 11906479 18543354 16397915 18299717 18209962 11145282 17977527 12498302 16631530 12787963 17627676 18193104 17918041 17657623 12077510 18181030 15104355 18237397 16755016 11595415 18431645 15255614 11523592 12500499 17654042 18726076 16252198 16934674 16169175 |
MESH:D013276 |
Stomach Ulcer |
|
Plant Extracts |
7.45 | 18193104 17135157 12787963 18237397 15255614 |
MESH:D020521 |
Stroke |
|
Acrolein |
10.24 | 16269634 |
MESH:D020521 |
Stroke |
|
Aspirin |
10.24 | 16403987 |
MESH:D020521 |
Stroke |
|
Folic Acid |
10.24 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.64 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
4.61 | 12563064 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
12.54 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
12.54 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Risperidone |
12.54 | 20210726 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Plant Extracts |
10.13 | 17997062 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
10.13 | 17997062 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.76 | 15464296 17225452 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
7.36 | 15821434 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
7.36 | 20479100 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
2.75 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
6.50 | 17672075 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
6.50 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
4.30 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
2.95 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
26.52 | 6587162 7505956 3712494 6582329 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
26.52 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
26.52 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
26.52 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
26.52 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Indomethacin |
26.52 | 14736730 18791128 11352223 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
26.52 | 3078959 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
26.52 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.74 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
11.83 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
11.83 | 16051514 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
11.83 | 16543248 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.04 | 15213294 |
MESH:D005879 |
Tourette Syndrome |
|
Risperidone |
5.03 | 19154706 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.28 | 17262798 |
MESH:D014202 |
Tremor |
|
Chlordecone |
5.03 | 6175765 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.57 | 16040207 |
MESH:D014456 |
Ulcer |
|
Indomethacin |
3.96 | 17380554 10574470 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.59 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
23.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.27 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
23.27 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
23.27 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
23.27 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
23.27 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
23.27 | 17306315 16712894 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
23.27 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
23.27 | 11723127 16712894 16452187 17306315 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
3.73 | 8888407 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.33 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.39 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
6.04 | 10982225 |
MESH:D014581 |
Urticaria |
|
Aspirin |
6.04 | 10982225 20485159 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
20.92 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
20.92 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
20.92 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
20.92 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
20.92 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.22 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
20.70 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
20.70 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
20.70 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
Sulindac |
20.70 | 18645019 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
20.70 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
9.68 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
9.68 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
8.84 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
8.84 | 11006244 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
8.06 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
8.06 | 16513791 16002989 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.49 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.64 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
2.69 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Plant Extracts |
7.52 | 18097624 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.52 | 17488730 |
MESH:D020257 |
Ventricular Remodeling |
|
Plant Extracts |
4.38 | 18097624 |
MESH:D014802 |
Vitamin A Deficiency |
|
Vitamin A |
4.40 | 16146918 16175781 16960172 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.17 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
8.39 | 11897121 |
MESH:D014839 |
Vomiting |
|
Indomethacin |
8.39 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.30 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
11.93 | 16402076 20107430 16141801 20521320 17502770 20564506 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
11.93 | 20107430 17933447 19434072 |
MESH:D015430 |
Weight Gain |
|
Risperidone |
11.93 | 16379507 20564506 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
4.15 | 17933447 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.15 | 16287080 |
MESH:D014947 |
Wounds and Injuries |
|
Plant Extracts |
3.47 | 20213670 19894650 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.49 | 17120751 |